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Little is currently known about the developmental origins of the immune system and the lineage restriction
processes that lead to its establishment. In this issue, Bo¨iers et al. (2013) nowdemonstrate immune-restricted
potential originating from the yolk sac even before the emergence of the first hematopoietic stem cells.During mouse embryonic development,
the first adult-repopulating hematopoietic
stem cells (HSCs) emerge at embryonic
day (E) 10.5 in the aorta-gonads-meso-
nephros (AGM) region from hemogenic
endothelial cells. Following their emer-
gence, HSCs migrate to the fetal liver
(FL) where they start differentiating to
produce a hematopoietic system that
resembles the adult hierarchy. Although
the emergence of definitive HSCs in
different tissues has been well docu-
mented, it is less clear when cells of the
adaptive immune system first arise in the
embryo. Because mammalian embryos
receive antibodies through the maternal
circulation and are protected from many
infections via the placental barrier, it was
long assumed that the lymphoid system
did not develop until later stages of
fetal development after the emergence
of HSCs. Bo¨iers et al. (2013) now provide
evidence that lymphoid potential emerges
at a much earlier stage than previously
thought, in the form of an immune-
restricted, lymphoid-primed cell popula-
tion before HSCs can be detected.
A number of different hematopoietic
cell types have been identified in the
mammalian embryo that arise prior to
the emergence of HSCs, which range
from multipotent progenitors that can
only repopulate when transplanted into
a neonatal or immunocompromised envi-
ronment to more mature cell types
including primitive erythrocytes and T- or
B-restricted progenitors (Yoshimoto
et al., 2011, 2012; and reviewed in Med-
vinsky et al., 2011). Generally speaking,
embryonic and fetal hematopoiesis can
be divided into three waves. It is now
well established that the embryo needs
both the first and the secondwave for sur-vival because their disruption will result
in early or late midgestation lethality,
respectively. The third wave is character-
ized by the emergence of HSCs and the
establishment of an adult-type hemato-
poietic tree. Surprisingly, disruption of
HSC production during this third wave
permits survival until birth (reviewed in
Frame et al., 2013). While the functions
of some of the blood cells that are gener-
ated as part of the first two waves have
been well described, including oxygen
supply to the rapidly growing embryo
and scavenging apoptotic cells and
debris produced during morphogenesis,
the importance of some of the other cell
types is less clear. Furthermore, while it
is known that some of these early blood
cells persist into adulthood and can give
rise to specialized tissue-resident macro-
phages in the adult (Schulz et al., 2012),
many of the others have been character-
ized with respect to their lineage output
by in vitro assays only, thus leaving the
question of their in vivo lineage potential
and contribution to adult hematopoiesis
unanswered.
To address the origin of the immune-
restricted progenitors, Bo¨iers et al. em-
ployed a Rag1-GFP reporter mouse to
track the cells’ emergence in vivo. No
Rag1GFP+IL7Ra+ cells were detected at
E8.5, but a small number was found in
the E9.5 yolk sac. Intriguingly, a sig-
nificant fraction of these E9.5 progenitors
expresses the hemogenic endothelium
marker VE-cadherin; however, the pre-
cise cellular origin of these immune-
restricted progenitors remains to be
identified, especially since previous re-
ports suggested that erythro-myeloid
progenitors and HSCs originate from
distinct endothelial cell populationsCell Stem Cell 13,(Chen et al., 2011). Short-term explant
cultures of embryonic yolk sac and para-
aortic splanchnopleura (the region that
gives rise to the AGM) were performed
before the onset of circulation at E8.5,
which showed that Rag1GFP+IL7Ra+
cells arose only in explanted yolk sacs.
Therefore, the yolk sac is the most likely
tissue of origin for these immune-
restricted progenitors.
Importantly, the authors also assessed
the lineage potential of these progenitors
in vivo, using Rag1-Cre fate mapping to
label cells that express Rag1 and their
progeny. Rag1-expressing progenitors
contributed to almost all B and T cells
emerging in the E14.5 FL, at the time
when an adult-type hematopoietic sys-
tem is established in the FL. Interestingly,
E11.5 FL immune-restricted progenitors
showed a marked upregulation of Ccr7
and Ccr9, two chemokine receptors
involved in cell migration to the thymus,
suggesting that they may seed the devel-
oping thymus. Rag1-labeled cells also
contributed to almost all B and T cells in
the adult bone marrow. Interestingly,
while these immune-restricted, lymphoid
primed progenitors gave rise to cells
from the Granulocyte-Monocyte (GM)
lineage, the branch of the myeloid system
that gives rise to cells of the innate im-
mune system, in the E11.5 and E14.5 FL,
this potential declined subsequently with
minimal Rag1 contribution to the GM
lineage in the bone marrow and no con-
tribution to the formation of tissue-resi-
dent macrophages in the adult. It should
also be noted that Rag1 regulatory ele-
ments continue to be active during adult
lymphopoiesis, thus precluding the
embryonic immune-restricted progenitor
contribution to the adult lymphoid cellNovember 7, 2013 ª2013 Elsevier Inc. 509
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Previewspool to be determined. To answer this
question would require an inducible sys-
tem in which Rag1-Cre expression can
be temporally controlled.
Just like the adult lymphoid-primed
multipotent progenitor (LMPP) identified
by the same group a few years ago
(Adolfsson et al., 2005), this LinKit+Flt3+
IL7Ra+ embryonic immune-restricted
progenitorhasGM,B,andTcell potentials,
but nomegakaryocyte-erythroid (MkE) po-
tential. These findings suggest that one of
the earliest hematopoietic lineage deci-
sions is a restriction process of the lym-
pho-myeloid lineage and a segregation of
this potential from the MkE lineage. Why
this lineage separation occurs at this early
stage is currently unclear, but may be ex-
plained by an earlier requirement for large
numbers of erythroid cells, which are pro-
vided first by the primitive wave and then
by the well-characterized erythro-myeloid
progenitor of the second wave, which
does not seem to possess lymphoid
potential and already arises at E8.25
(reviewed in Frame et al., 2013). Whether
these two important early progenitors,
the erythro-myeloid progenitor and the
immune-restricted progenitor, share a
commonorigin andmight even havediffer-
entiated from the same precursors re-
mains to be explored.510 Cell Stem Cell 13, November 7, 2013 ª2The immune-restricted progenitor iden-
tified in this study may also prove relevant
to the study of pediatric leukemias, some
of which are known to initiate in utero.
While most patients present with acute
lymphoblastic leukemia, some are diag-
nosed with poor prognosis biphenotypic
leukemia, suggesting that the cell of origin
possessed both lymphoid and myeloid
potentials. Since the myeloid potential
of the immune-restricted progenitor
identified by Bo¨iers et al. was shown to
decrease over the course of develop-
ment, it may also provide crucial clues
as to the timing of preleukemic transloca-
tions. For this cell to become a useful
therapeutic target, however, would
require further studies into its in vivo
function. Nevertheless, Bo¨iers et al.’s
identification of an LMPP-like cell present
in the mammalian embryo as early as
E9.5, prior to the emergence of HSCs,
represents an important study as it
sheds light on the development of
both the myeloid innate and lymphoid
adaptive immune system and describes
the myeloid-lymphoid versus MkE res-
triction as one of the earliest hematopoi-
etic lineage decisions. It also highlights
the role of the yolk sac in setting up the
first hematopoietic/immune system dur-
ing development.013 Elsevier Inc.REFERENCES
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Recently in Cell, Wapinski et al. (2013) investigated the epigenetic mechanisms underlying the direct conver-
sion of fibroblasts to induced neurons (iNs). They found that Ascl1 acts as a pioneer factor at neurogenic loci
marked by a closed ‘‘trivalent’’ chromatin state in cells permissive to direct conversion, but not in restrictive
cell types.Lineage-specific transcription factors
define cell fate during development. Intu-
itively, ectopic overexpression of these
transcription factors can redirect cell
fate. One of the most dramatic examples
of engineered cell fate change is the deri-
vation of induced pluripotent stem cells(iPSCs) by four transcription factors
(classically Oct4, Sox2, Klf4, and c-Myc)
that reprogram fully differentiated cells
to a pluripotent state (Takahashi and
Yamanaka, 2006). This successful cel-
lular conversion to pluripotency has also
encouraged efforts to directly reprogramone cell type to another. Although exam-
ples of direct reprogramming, or transdif-
ferentiation, already existed prior to the
advent of iPSC technology (Graf, 2011),
they have primarily involved switching
between related cells in a lineage within
the same germ layer, such as the
